L
LENSAR, Inc. (LNSR)
NCM – Real Time Price. Currency in USD
6.07
+0.55 (9.96%)
At close: Mar 27, 2026, 4:00 PM EDT
6.12
+0.05 (0.82%)
After-hours: Mar 27, 2026, 7:51 PM EDT
Get all premium features to the best stock analysis tool
NCM – Real Time Price. Currency in USD
6.07
+0.55 (9.96%)
At close: Mar 27, 2026, 4:00 PM EDT
6.12
+0.05 (0.82%)
After-hours: Mar 27, 2026, 7:51 PM EDT
LENSAR, Inc., a commercial-stage medical device company, focuses on designing, developing, and marketing laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism in the United System. The company offers LENSAR Laser System which incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes by providing imaging, procedure planning, design, and precision. It also provides ALLY Robotic Cataract Laser System, a compact cataract treatment system that is designed to allow surgeons to perform sterile laser-assisted cataract surgery in a single operating room. LENSAR, Inc. was incorporated in 2004 and is headquartered in Orlando, Florida.
| Name | Position |
|---|---|
| Mr. Alan B. Connaughton | Chief Operating Officer |
| Mr. Nicholas T. Curtis | President, CEO & Director |
| Mr. Thomas R. Staab II, CPA | CFO & Secretary |
| Ms. Kendra W. Wong | Principal Accounting Officer |
| Date | Type | Document |
|---|---|---|
| 2026-03-17 | 8-K | d27242d8k.htm |
| 2026-03-13 | 8-K/A | d119017d8ka.htm |
| 2026-03-12 | 8-K | lnsr-20260312.htm |
| 2025-12-19 | 8-K | lnsr-20251218.htm |
| 2025-11-06 | 10-Q | lnsr-20250930.htm |
| 2025-11-05 | DEF 14A | lnsr-proxy-2025.htm |
| 2025-10-21 | 8-K | lnsr-20251015.htm |
| 2025-08-07 | 8-K | lnsr-20250807.htm |
| 2025-07-02 | 8-K | lnsr-20250702.htm |
| 2025-06-25 | DEFA14A | d98597ddefa14a.htm |